56 followers
RT @dhovekamp42: Potential of #TCR T-cell therapy vs. CAR-T - summary overview 2022 - cc $ADAP $GSK $IMTX $LYEL Zhang, Y., Liu, Z., Wei…
RT @dhovekamp42: Potential of #TCR T-cell therapy vs. CAR-T - summary overview 2022 - cc $ADAP $GSK $IMTX $LYEL Zhang, Y., Liu, Z., Wei…
Potential of #TCR T-cell therapy vs. CAR-T - summary overview 2022 - cc $ADAP $GSK $IMTX $LYEL Zhang, Y., Liu, Z., Wei, W. et al. TCR engineered T cells for solid tumor immunotherapy. Exp Hematol Oncol 11, 38 (2022). https://t.co/WBWk7S6Q2h https://t.